Molecular Diagnostics News and Research

RSS

Breakthrough in Malaria detection: new FREM platform delivers 98% accuracy for rapid screening and genotyping

The Flexible, Robust, Equipment-free Microfluidic (FREM) platform for malaria screening and Plasmodium species genotyping.

1 Dec 2023

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

Cell Signaling Technology (CST), a life science biotechnology company and leading provider of antibodies, kits, and services, and Amoy Diagnostics Co., Ltd. (AmoyDx), a China-based innovative molecular diagnostics company in the field of precision oncology, announced today the expansion of their ongoing partnership for companion diagnostic (CDx) development in China.

From Cell Signaling Technology 23 Nov 2023

Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries

Yourgene Health (part of the Novacyt group of companies) today announced a collaboration to optimize size selection for long-read sequencing workflows.

From Yourgene Health 22 Nov 2023

Novel assay may improve detection and treatment of acute myeloid leukemia

A novel assay that detects a unique molecular marker in patients with acute myeloid leukemia (AML) may revolutionize the way this disease is detected and treated according to a new report in The Journal of Molecular Diagnostics published by Elsevier.

13 Nov 2023

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

City of Hope, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an international group that has been awarded $4.5 million to validate a liquid biopsy for the early detection of pancreatic cancer.

26 Oct 2023

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

At the height of the COVID-19 pandemic, Virginia Tech disease ecologists wondered if the virus was having the same effect on wildlife.

24 Oct 2023

UCLA receives grant to improve liquid biopsy for early lung cancer detection

A team of investigators from the UCLA Jonsson Comprehensive Cancer Center and the UCLA School of Dentistry received a five-year $4.6 million grant from the National Cancer Institute to develop and improve liquid biopsy technologies for the early detection of lung cancer -; the leading cause of cancer death in both men and women in the U.S.

13 Oct 2023

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

Circulating tumor DNA (ctDNA) is emerging as a blood-based biomarker for many solid tumor types, including melanoma.

4 Oct 2023

New blood test for sepsis could save lives and money

Sepsis is a life-threatening medical emergency that occurs when an infection causes a chain reaction throughout the body that can lead to the failure of multiple organs in rapid succession.

26 Sep 2023

Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT workflows

Yourgene Health plc (“Yourgene”), a leading international molecular diagnostics group, today launched the Yourgene® MagBench™ Automated DNA Extraction Instrument and Kit. MagBench solution is available to Sage™ customers across Asia-Pacific and the Middle East.

From Yourgene Health 5 Sep 2023

New diagnostic tool could revolutionize early bladder cancer detection

Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as the disease progresses to advanced stages.

14 Aug 2023

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, today published a new study explaining how they took a protein once thought to be too challenging for targeted therapy, proliferating cell nuclear antigen (PCNA), and developed a targeted chemotherapy that appears to annihilate all solid tumors in preclinical research.

1 Aug 2023

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

10 Jul 2023

$Yourgene Health presents data demonstrating successful fetal fraction enrichment in NIPT workflows following prolonged blood storage in EDTA tubes$

Yourgene Health presents data demonstrating successful fetal fraction enrichment in NIPT workflows following prolonged blood storage in EDTA tubes

Yourgene Health plc, a leading international molecular diagnostics group, today presented data demonstrating that prolonged storage of blood in EDTA tubes is compatible with non-invasive prenatal testing (NIPT) when using size selection to enrich the fetal fraction.

From Yourgene Health 19 Jun 2023

Molecular Diagnostics News and Research

Breakthrough in Malaria detection: new FREM platform delivers 98% accuracy for rapid screening and genotyping

AmoyDx and CST Expand Existing Partnership for the Development of Companion Diagnostics (CDx) to Support Precision Oncology

Yourgene Health becomes a PacBio compatible partner: Enabling PacBio customers to optimize size selection for long-read sequencing libraries

Novel assay may improve detection and treatment of acute myeloid leukemia

City of Hope, TGen receive $4.5 million to validate liquid biopsy for early detection of pancreatic cancer

New research aims to understand the ecology of SARS-CoV-2 at the human-animal interface

UCLA receives grant to improve liquid biopsy for early lung cancer detection

Measuring ctDNA may lead to alternative treatment options for BRAF wild-type melanoma

New blood test for sepsis could save lives and money

Yourgene Health launches MagBench Automated DNA Extraction Instrument and Kit for NIPT workflows

New diagnostic tool could revolutionize early bladder cancer detection

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

AMP releases consensus recommendations for CYP3A4 and CYP3A5 genotyping assays

Yourgene Health presents data demonstrating successful fetal fraction enrichment in NIPT workflows following prolonged blood storage in EDTA tubes

UK’s first Centre for Phage Research highlights Actiphage in the KTN UK Phage Innovation Showcase

New process for automated and highly accurate reporting of NGS-based clonality testing

Overcoming challenges in Point of Care diagnostics in veterinary medicine

How can Europe tackle its unfinished tuberculosis business?

Point-of-care test identifies patients who may benefit from hypnosis interventions for pain treatment

Women-focused diagnostics start-up wins INTEGRA Biosciences’ EVOLVE pipettes

E-Cigarettes and Ethanol: A forensic Perspective on Vaping

Understanding Consumer-Consented Data to Optimize Digital Health Programs

The Future is Wearable: Advancing Human Health Through Portable Spectroscopy

Latest News